⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

December 1, 1986Antimicrobial Agents and ChemotherapyOpen Access

Association between colistin resistance and broad-spectrum recipient deficiency in Klebsiella pneumoniae

M Lamousin-White Richard J. O’Callaghan

View Full Paper

Ask AI

Bookmark

Share

Abstract

A colistin-resistant mutant of Klebsiella pneumoniae served well as a donor but not as a recipient in conjugation. A nearly 1,000-fold difference between colistin-susceptible and colistin-resistant forms of this strain was observed by using donors of plasmids of four incompatibility groups. Recipient efficiency was not restored by filter matings.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Lamousin-White et al. (1986) studied this question.

synapsesocial.com/papers/6a762d77756843cacbb25225 https://doi.org/10.1128/aac.30.6.964

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1Activity of oral β-lactams, tebipenem and ceftibuten, combined with novel oral β-lactamase inhibitors against broad-spectrum β-lactamase-producing Escherichia coliAntimicrobial Agents and Chemotherapy · Wed,
2Rifampicin-resistant Staphylococcus epidermidis implant-associated infections: the therapeutic potential of ceftaroline and daptomycin combinationsAntimicrobial Agents and Chemotherapy · Wed,
3Expanding threat of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in Peru: genomic and phenotypic evidence of high-risk clones disseminationAntimicrobial Agents and Chemotherapy · Wed,
4A multivalent CPS-CRM197 conjugate vaccine protects against severe/fatal Klebsiella pneumoniae disease in a mouse infection modelAntimicrobial Agents and Chemotherapy · Wed,
5In vitro and in vivo activity of OSUAB-0284, a preclinical candidate for Staphylococcus aureus infectionsAntimicrobial Agents and Chemotherapy · Thu,

More from Antimicrobial Agents and Chemotherapy

Dual-stage inhibition of Plasmodium falciparum by a Skeletocutis -derived fungal metabolite targeting pyruvate kinase IITue,
Pharmacokinetic/pharmacodynamic evaluation of multidose oritavancin for prolonged durations of therapyWed,
A machine learning framework for precision dosing of daptomycin across diverse disease statesWed,
Population pharmacokinetics of piperacillin based on multicenter data to support model-informed precision dosing in critically ill womenWed,
In vitro activity of gepotidacin against baseline Neisseria gonorrhoeae phenotypes and genotypes recovered from a clinical trial for uncomplicated urogenital gonorrhea (EAGLE-1)Wed,